This brand name is authorized in Nigeria.
The drug TRIVALAM H contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
1J444QC288 - AMLODIPINE
|
|
Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. |
|
2
|
UNII
80M03YXJ7I - VALSARTAN
|
|
Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT1-receptor subtype, which is responsible for the known actions of angiotensin II. |
|
3
|
UNII
0J48LPH2TH - HYDROCHLOROTHIAZIDE
|
|
Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-100774 | Tablet | Trivalam H Tablet TAB 10 mg; 160 mg; 25 mg 3 x 10's (in PVC blisters) | Film Coated Tablet Round, white tablet with a score line on one side of the tablet 25 NF-PP-280370 TRIVALAM H Tablet Amlodipine/Valsartan/Hydrochlorothiazide Tablet Amlodipine 10mg, Valsartan 160mg, Hydrochlorothiazide 25mg, Lactose Monohydrate, Microcrystalline cellulose, Croscarmellose Sodium, Crospovidone, Magnesium Stearate, Anhydrous colloidal silica, Opadry II white A4-100774 Drugs Imported Products 103packs Prescription Only Medicine (POM) 8/9/2023 EXPHARLAB LIMITED, 387, AGEGE MOTOR ROAD, MUSHIN LAGOS LAGOS | 27/03/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C08CA01 | Amlodipine | C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives |
| C09DX01 | Valsartan, amlodipine and hydrochlorothiazide | C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DX Angiotensin II antagonists, other combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-100774 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.